Recent studies indicate that the therapeutic option for depression is via the restoration of astrocytes function, AQP4, and glymphatic system (131, 132), which provide further supporting evidence for the critical role of glymphatic flow in depression. This evidence concerns the gene AQP4 and depressive disorder.